Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
CVRx, Inc. (CVRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/25/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
8-K
| Investor presentation|
Docs:
|
"2 Cautionary Note Regarding Forward-Looking Statement This presentation by CVRx, Inc. contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including statements regarding our future financial performance , our anticipated growth strategies, anticipated trends in our industry, our business prospects and our opportunities. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “outlook,” “guidance,” “intend,” “target,..." |
|
| 05/26/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/21/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/21/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 03/15/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ... |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/10/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/06/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/26/2023 |
8-K
| Quarterly results|
Docs:
|
"CVRx, INC. Condensed Consolidated Balance Sheets December 31, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 106,194 $ 142,072 Accounts receivable, net of allowances of $679 and $0, respectively 5,504 2,560 Inventory 6,957 3,880 Prepaid expenses and other current assets 4,223 2,585 Total current assets 122,878 151,097 Property and equipment, net 1,698 1,425 Operating lease right-of-use asset 334 — Other non-current assets 27 26 Total assets $ 124,937 $ 152,548 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 1,719 $ 510 Accrued expenses 6,369 5,398 Total current liabilities 8,088 5,908 Long-term debt 6,747 — Operating lease liability, non-current portion 117 — Other long-term liabilities 805 681 Total liabilities 15,757 6,589 Commitme..." |
|
| 01/09/2023 |
8-K
| Quarterly results |
| 12/20/2022 |
8-K
| Quarterly results |
| 11/16/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/15/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 11/04/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 11/04/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/01/2022 |
8-K
| Quarterly results|
Docs:
|
"Loan and Security Agreement, among CVRx, Inc., Innovatus Life Sciences Fund I, LP, as the collateral agent and a lender, and the other lenders from time to time party thereto",
"CVRx, INC. Condensed Consolidated Balance Sheets September 30, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 109,985 $ 142,072 Accounts receivable, net 5,297 2,560 Inventory 6,064 3,880 Prepaid expenses and other current assets 3,066 2,585 Total current assets 124,412 151,097 Property and equipment, net 1,747 1,425 Operating lease right-of-use asset 391 — Other non-current assets 26 26 Total assets $ 126,576 $ 152,548 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 1,276 $ 510 Accrued expenses 6,120 5,398 Total current liabilities 7,396 5,908 Operating lease liability, non-current portion 175 — Other long-term liabilities 761 681 Total liabilities 8,332 6,589 Commitments and contingencies Stockholders’ equity: Common stock, $0.01 pa..." |
|
| 08/01/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/28/2022 |
8-K
| Quarterly results |
| 06/09/2022 |
8-K
| Quarterly results |
| 05/02/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/29/2022 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.1% stake in CVRx, INC. |
| 04/25/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/25/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/25/2022 |
8-K
| Quarterly results|
Docs:
|
"CVRx, INC. Condensed Consolidated Balance Sheets March 31, December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 131,177 $ 142,072 Accounts receivable, net 3,673 2,560 Inventory 5,261 3,880 Prepaid expenses and other current assets 2,090 2,585 Total current assets 142,201 151,097 Property and equipment, net 1,656 1,425 Operating lease right-of-use asset 522 — Other non-current assets 26 26 Total assets $ 144,405 $ 152,548 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 1,607 $ 510 Accrued expenses 4,985 5,398 Total current liabilities 6,592 5,908 Operating lease liability, non-current portion 304 — Other long-term liabilities 706 681 Total liabilities 7,602 6,589 Commitments and contingencies Stockholders’ equity : Common stock, $0.01 par v..." |
|
| 02/22/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/22/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
|
|
|